Brief: Gyre Therapeutics Entered Into Open Market Sale Agreement, May Offer & Sell Shares Of Common Stock Of Up To $50 Million From Time To Time
27/11/2024 23:21
Nov 27 (Reuters) - Gyre Therapeutics Inc GYRE.O :
* GYRE THERAPEUTICS: ENTERED INTO OPEN MARKET SALE
AGREEMENT, MAY
OFFER & SELL SHARES OF COMMON STOCK OF UP TO $50 MILLION FROM
TIME TO TIME - SEC FILING
Source text: ID:n0001140361-24-047979
Further company coverage: GYRE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gyre Therapeutics
See all newsBrief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Gyre Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Gyre Therapeutics, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Brief: Gyre Therapeutics Reports Second Quarter 2026
Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumes